iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/31814058/
Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson's disease: a systematic review - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;44(1):115-127.
doi: 10.1007/s10143-019-01216-y. Epub 2019 Dec 9.

Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson's disease: a systematic review

Yangyang Xu #  1 , Qi He #  2 , Mengqi Wang  1 , Yuan Gao  1 , Xiaowei Liu  1 , Denghui Li  1 , Botao Xiong  1 , Wei Wang  3
Affiliations

Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson's disease: a systematic review

Yangyang Xu et al. Neurosurg Rev. 2021 Feb.

Abstract

Magnetic resonance imaging-guided focused ultrasound (MRgFUS) neurosurgery is a new option for medication-resistant Parkinson's disease (PD), but its safety and efficacy remain elusive. This study aimed to investigate the safety and efficacy of MRgFUS for PD by systematically reviewing related literature. PubMed and EMBASE were searched to identify related studies. Inclusion criteria were (1) reported the efficacy or safety of MRgFUS for PD and (2) published in English. Exclusion criteria were (1) nonhuman study, (2) review or meta-analysis or other literature types without original data, and (3) conference abstract without full text. Data on study characteristics, treatment parameters, efficacy, and adverse events were collected. Descriptive synthesis of data was performed. Eleven studies containing 80 patients were included. Nine studies were observational studies with no controls. Two studies included a randomized and controlled phase. Most studies included tremor-dominant PD. Ten studies reported decline of UPDRS-III scores after MRgFUS, and five reported a statistically significant decline. Nine studies evaluated the quality of life (QOL). Significant improvement of QOL was reported by four studies using the 39-item Parkinson's disease questionnaire. Four studies investigated the impact of MRgFUS on non-motor symptoms. Most tests indicated that MRgFUS had no significant effect on neuropsychological outcomes. Most adverse events were mild and transient. MRgFUS is a potential treatment for PD with satisfying efficacy and safety. Studies in this field are still limited. More studies with strict design, larger sample size, and longer follow-up are needed to further investigate its efficacy and safety for PD.

Keywords: Efficacy; Magnetic resonance imaging-guided focused ultrasound; Parkinson’s disease; Safety; Systematic review.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. A Sinai, M Nassar, A Eran, M Constantinescu, M Zaaroor, E Sprecher, I Schlesinger (2019) Magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: a 5-year single-center experience. J Neurosurg:1–8
    1. Bauer R, Martin E, Haegele-Link S, Kaegi G, von Specht M, Werner B (2014) Noninvasive functional neurosurgery using transcranial MR imaging-guided focused ultrasound. Parkinsonism Relat Disord 20(Suppl 1):S197–S199. https://doi.org/10.1016/s1353-8020(13)70046-4 - DOI - PubMed
    1. Bohlhalter S, Kägi G, Kaelin A, Haegele-Link S, Burkhard PR, Pollo C, Schüpbach M, Baumann C, Bassetti CL (2014) Transcranial magnetic resonance imaging-guided focused ultrasound in Parkinson's disease. Schweizer Archiv fur Neurologie und Psychiatrie 165:139–140 - DOI
    1. Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, Sperling SA, Wang XQ, Gwinn R, Witt J, Ro S, Elias WJ (2017) Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial. JAMA Neurol 74:1412–1418. https://doi.org/10.1001/jamaneurol.2017.3098 - DOI - PubMed - PMC
    1. Chang WS, Jung HH, Zadicario E, Rachmilevitch I, Tlusty T, Vitek S, Chang JW (2016) Factors associated with successful magnetic resonance–guided focused ultrasound treatment: efficiency of acoustic energy delivery through the skull. J Neurosurg 124:411–416. https://doi.org/10.3171/2015.3.JNS142592 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources